Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1

Status

Recruiting 3

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

CNS 2

Conditions

Neoplasms, Nerve Tissue 2Neoplasms 2Glioma 2Glioblastoma 2Brain Neoplasms 2Ascites 1Abdominal Neoplasms 1Abdominal Injuries 1

Interventions

pembrolizumab 1281Specimen Handling 927Carboplatin 835Magnetic Resonance Spectroscopy 834Cyclophosphamide 809Cisplatin 733Nivolumab 683Paclitaxel 638Radiotherapy 614Gemcitabine 582Biopsy 558Bevacizumab 482Dexamethasone 446fludarabine 411Docetaxel 385venetoclax 371Oxaliplatin 368Capecitabine 364Fluorouracil 360atezolizumab 346durvalumab 340Rituximab 334Drug Therapy 332Doxorubicin 319Blood Specimen Collection 317Radiosurgery 317Standard of Care 311Pemetrexed 307Ipilimumab 306Radiation 286

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
contrast agent BR1 × 1 year × Clear all
NCT06329570 2026-04-09

Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM)

NaviFUS Corporation

Phase 1/2 Recruiting
10 enrolled
CNS

Brain Neoplasms, Glioblastoma, Glioma, Neoplasms, Neoplasms, Nerve Tissue

NCT06496971 2026-04-09

A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients

NaviFUS Corporation

Phase 3 Recruiting
32 enrolled
CNS

Brain Neoplasms, Glioblastoma, Glioma, Neoplasms, Neoplasms, Nerve Tissue

NCT07113808 2025-12-08

CEUS

The Children's Hospital of Zhejiang University School of Medicine

Recruiting
108 enrolled

Abdominal Injuries, Abdominal Neoplasms, Ascites

Data powered by HemOnc (CC BY 4.0) Colophon âš¡